- Home
- SUN vs IONS Comparison
SUN vs IONS Comparison
Compare SUN & IONS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUN
- IONS
- Stock Information
- Founded
- SUN 1886
- IONS 1989
- Country
- SUN United States
- IONS United States
- Employees
- SUN N/A
- IONS N/A
- Industry
- SUN Integrated oil Companies
- IONS Biotechnology: Pharmaceutical Preparations
- Sector
- SUN Energy
- IONS Health Care
- Exchange
- SUN Nasdaq
- IONS Nasdaq
- Market Cap
- SUN 7.3B
- IONS 6.0B
- IPO Year
- SUN N/A
- IONS 1991
- Fundamental
- Price
- SUN $59.19
- IONS $32.43
- Analyst Decision
- SUN Buy
- IONS Buy
- Analyst Count
- SUN 8
- IONS 18
- Target Price
- SUN $63.25
- IONS $62.00
- AVG Volume (30 Days)
- SUN 604.5K
- IONS 1.6M
- Earning Date
- SUN 02-11-2025
- IONS 02-19-2025
- Dividend Yield
- SUN 5.97%
- IONS N/A
- EPS Growth
- SUN N/A
- IONS N/A
- EPS
- SUN 4.57
- IONS N/A
- Revenue
- SUN $23,065,000,000.00
- IONS $803,067,000.00
- Revenue This Year
- SUN $1.86
- IONS N/A
- Revenue Next Year
- SUN $3.44
- IONS $9.79
- P/E Ratio
- SUN $12.95
- IONS N/A
- Revenue Growth
- SUN N/A
- IONS 30.57
- 52 Week Low
- SUN $49.45
- IONS $31.03
- 52 Week High
- SUN $64.89
- IONS $52.34
- Technical
- Relative Strength Index (RSI)
- SUN 72.26
- IONS 41.49
- Support Level
- SUN $55.94
- IONS $31.03
- Resistance Level
- SUN $58.00
- IONS $33.77
- Average True Range (ATR)
- SUN 1.46
- IONS 1.37
- MACD
- SUN 0.42
- IONS -0.06
- Stochastic Oscillator
- SUN 93.47
- IONS 24.42
About SUN Sunoco LP Common Units representing limited partner interests
Sunoco LP engaged in the distribution of motor fuels to independent dealers, distributors, and other commercial customers as well as the distribution of motor fuels to end-use customers at retail sites operated by commission agents. It is a growth-oriented master limited partnership (MLP) that operates as a wholesale and retail fuel distributor in the United States. The firm operates through the Fuel Distribution and Marketing segment. It distributes motor fuel to convenience stores, dealers, and commercial customers in various states. The operating convenience stores are under the APlus, Stripes, Aloha Island Mart, and Tigermarket brands.
About IONS Ionis Pharmaceuticals Inc.
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and partner Biogen brought Spinraza to market in 2016 as a treatment for a rare neuromuscular disorder, spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019). Ionis and AstraZeneca launched polyneuropathy drug Wainua in 2024.